Energetic dysfunction in sepsis: a narrative review

[1]  B. Mizaikoff,et al.  Metabolic substrate utilization in stress-induced immune cells , 2020, Intensive Care Medicine Experimental.

[2]  C. Hong,et al.  Current Understanding on the Metabolism of Neutrophils , 2020, Immune network.

[3]  S. Bailly,et al.  Sepsis and septic shock in France: incidences, outcomes and costs of care , 2020, Annals of Intensive Care.

[4]  L. Boerger,et al.  Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19 , 2020, Critical Care.

[5]  X. Nuvials,et al.  Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review , 2020, Annals of Intensive Care.

[6]  U. Lendahl,et al.  Regulation of Mammalian Mitochondrial Dynamics: Opportunities and Challenges , 2020, Frontiers in Endocrinology.

[7]  P. Pickkers,et al.  Norepinephrine Dysregulates the Immune Response and Compromises Host Defense During Sepsis. , 2020, American journal of respiratory and critical care medicine.

[8]  G. Davis.  Not Fade Away: Mechanisms of Neuronal ATP Homeostasis , 2020, Neuron.

[9]  M. Chan,et al.  Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis , 2020, Annals of Intensive Care.

[10]  Y. An,et al.  External validity of Adult Sepsis Event’s simplified eSOFA criteria: a retrospective analysis of patients with confirmed infection in China , 2020, Annals of Intensive Care.

[11]  E. Schroder,et al.  Contemporary Review in Critical Care Medicine:Mitochondria and Critical Illness. , 2020, Chest.

[12]  S. Jaber,et al.  Mitochondrial oxidative stress induces leaky ryanodine receptor during mechanical ventilation. , 2019, Free radical biology & medicine.

[13]  J. Kellum,et al.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. , 2019, Kidney international.

[14]  W. Nauseef.  The phagocyte NOX2 NADPH oxidase in microbial killing and cell signaling. , 2019, Current opinion in immunology.

[15]  Gagan Dev,et al.  Functionally significant metabolic differences between B and T lymphocyte lineages , 2019, Immunology.

[16]  L. Forni,et al.  Understanding Lactatemia in Human Sepsis: Potential Impact for Early Management. , 2019, American journal of respiratory and critical care medicine.

[17]  Qingjun Pan,et al.  Disturbance of mitochondrial dynamics and mitophagy in sepsis-induced acute kidney injury. , 2019, Life sciences.

[18]  Liheng Guo,et al.  The Role of Autophagy in Sepsis: Protection and Injury to Organs , 2019, Front. Physiol..

[19]  David L. Williams,et al.  Loss of monocyte metabolic plasticity in endotoxin tolerance: A model for understanding sepsis‐induced immune paralysis? , 2019, Journal of leukocyte biology.

[20]  T. A. Ryan,et al.  Molecular Tuning of the Axonal Mitochondrial Ca2+ Uniporter Ensures Metabolic Flexibility of Neurotransmission , 2019, Neuron.

[21]  P. Parrilla,et al.  P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis , 2019, Nature Communications.

[22]  P. Radermacher,et al.  Preclinical septic shock research: why we need an animal ICU , 2019, Annals of Intensive Care.

[23]  M. Netea,et al.  Frontline Science: Endotoxin‐induced immunotolerance is associated with loss of monocyte metabolic plasticity and reduction of oxidative burst , 2019, Journal of leukocyte biology.

[24]  Jun Ren,et al.  Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[25]  Ying Wang,et al.  Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis , 2019, Annals of Intensive Care.

[26]  C. Piantadosi,et al.  Peripheral Blood Mononuclear Cells Demonstrate Mitochondrial Damage Clearance During Sepsis , 2019, Critical care medicine.

[27]  M. Singer,et al.  The role of mitochondria in sepsis-induced cardiomyopathy. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[28]  E. Sherwood,et al.  Metabolism drives monocytes during inflammation: What we do and do not know , 2019, Journal of leukocyte biology.

[29]  C. McCall,et al.  Frontline Science: Monocytes sequentially rewire metabolism and bioenergetics during an acute inflammatory response , 2019, Journal of leukocyte biology.

[30]  Michael T. Eadon,et al.  Bacterial sepsis triggers an antiviral response that causes translation shutdown , 2018, The Journal of clinical investigation.

[31]  B. Petrof.  Diaphragm Weakness in the Critically Ill: Basic Mechanisms Reveal Therapeutic Opportunities , 2018, Chest.

[32]  J. Minei,et al.  Beclin-1-Dependent Autophagy Protects the Heart During Sepsis , 2018, Circulation.

[33]  G. Piraino,et al.  Age-dependent cardiac function during experimental sepsis: effect of pharmacological activation of AMP-activated protein kinase by AICAR. , 2018, American journal of physiology. Heart and circulatory physiology.

[34]  M. Martín-Pastor,et al.  Lipopolysaccharide (LPS)-induced septic shock causes profound changes in myocardial energy metabolites in pigs , 2018, Metabolomics.

[35]  Tanshi Li,et al.  Association between the T6459C point mutation of the mitochondrial MT‐CO1 gene and susceptibility to sepsis among Chinese Han people , 2018, Journal of cellular and molecular medicine.

[36]  C. Libert,et al.  Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? , 2018, EMBO molecular medicine.

[37]  E. Pearce,et al.  Unraveling the Complex Interplay Between T Cell Metabolism and Function. , 2018, Annual review of immunology.

[38]  M. Inglot,et al.  Liver dysfunction in sepsis. , 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[39]  F. Meziani,et al.  Septic Shock Alters Mitochondrial Respiration of Lymphoid Cell-Lines and Human Peripheral Blood Mononuclear Cells: The Role of Plasma , 2018, Shock.

[40]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[41]  S. Snyder,et al.  Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases , 2018, British journal of pharmacology.

[42]  Publisher's Note , 2018, Anaesthesia.

[43]  Mervyn Singer,et al.  Critical illness and flat batteries , 2017, Critical Care.

[44]  C. Ottenheijm,et al.  Diaphragm Atrophy and Weakness in the Absence of Mitochondrial Dysfunction in the Critically Ill , 2017, American journal of respiratory and critical care medicine.

[45]  D. Eckmann,et al.  Mitochondrial networking in human blood cells with application in acute care illnesses. , 2017, Mitochondrion.

[46]  R. Favory,et al.  Involvement of Mitochondrial Disorders in Septic Cardiomyopathy , 2017, Oxidative medicine and cellular longevity.

[47]  G. Reiser,et al.  Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration , 2017, Neurochemistry International.

[48]  B. Nussbaum,et al.  Non-Hemodynamic Effects of Catecholamines. , 2017, Shock.

[49]  Joel s. Brown,et al.  The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand , 2017, PloS one.

[50]  M. Nijsten,et al.  The association of early combined lactate and glucose levels with subsequent renal and liver dysfunction and hospital mortality in critically ill patients , 2017, Critical Care.

[51]  E. Zakynthinos,et al.  Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies , 2017, Oxidative medicine and cellular longevity.

[52]  P. Bhargava,et al.  Mitochondrial energetics in the kidney , 2017, Nature Reviews Nephrology.

[53]  Niranjan Kissoon,et al.  Recognizing Sepsis as a Global Health Priority - A WHO Resolution. , 2017, The New England journal of medicine.

[54]  J. Takala,et al.  Mitochondrial function of immune cells in septic shock: A prospective observational cohort study , 2017, PloS one.

[55]  John D Lambris,et al.  Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects , 2017, The Journal of Immunology.

[56]  C. A. Prauchner.  Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy. , 2017, Burns : journal of the International Society for Burn Injuries.

[57]  S. Emani,et al.  Mitochondrial transplantation: From animal models to clinical use in humans. , 2017, Mitochondrion.

[58]  M. Brand,et al.  Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements , 2017, The Journal of Biological Chemistry.

[59]  J. Kellum,et al.  Metabolic reprogramming and tolerance during sepsis-induced AKI , 2017, Nature Reviews Nephrology.

[60]  R. Hotchkiss,et al.  Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis* , 2017, Critical care medicine.

[61]  Kelvin E. Jones,et al.  Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure. , 2017, American journal of physiology. Heart and circulatory physiology.

[62]  W. Liles,et al.  PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis. , 2017, American journal of physiology. Heart and circulatory physiology.

[63]  Brett C. Hannigan,et al.  Mitigation of Ventilator‐induced Diaphragm Atrophy by Transvenous Phrenic Nerve Stimulation , 2017, American journal of respiratory and critical care medicine.

[64]  F. Guo,et al.  Endotoxemia accelerates diaphragm dysfunction in ventilated rabbits. , 2016, The Journal of surgical research.

[65]  M. Shankar-Hari,et al.  Differences in Impact of Definitional Elements on Mortality Precludes International Comparisons of Sepsis Epidemiology—A Cohort Study Illustrating the Need for Standardized Reporting* , 2016, Critical care medicine.

[66]  Marcelo Park,et al.  Sepsis-3 definitions predict ICU mortality in a low–middle-income country , 2016, Annals of Intensive Care.

[67]  T. van der Poll,et al.  Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis. , 2016, American journal of respiratory and critical care medicine.

[68]  R. Hotchkiss,et al.  Sepsis and septic shock , 2016, Nature Reviews Disease Primers.

[69]  E. Ruiz-Pesini,et al.  Septic patients with mitochondrial DNA haplogroup JT have higher respiratory complex IV activity and survival rate. , 2016, Journal of critical care.

[70]  E. Carchman,et al.  Sepsis results in an altered renal metabolic and osmolyte profile. , 2016, The Journal of surgical research.

[71]  F. Saulnier,et al.  Endotoxemia Engages the RhoA Kinase Pathway to Impair Cardiac Function By Altering Cytoskeleton, Mitochondrial Fission, and Autophagy. , 2016, Antioxidants & redox signaling.

[72]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[73]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[74]  J. Kline,et al.  Early alterations in platelet mitochondrial function are associated with survival and organ failure in patients with septic shock. , 2016, Journal of critical care.

[75]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[76]  M. Elkalaf,et al.  Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness , 2015, Critical Care.

[77]  S. Opal,et al.  PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS , 2015, Shock.

[78]  In Seon Lee,et al.  Prognostic implications of serum lipid metabolism over time during sepsis , 2015, Intensive Care Medicine Experimental.

[79]  E. Ruiz-Pesini,et al.  Decrease of oxidative phosphorylation system function in severe septic patients. , 2015, Journal of critical care.

[80]  Juanjuan Lyu,et al.  Sepsis-induced brain mitochondrial dysfunction is associated with altered mitochondrial Src and PTP1B levels , 2015, Brain Research.

[81]  R. Rossignol,et al.  Redox Homeostasis and Mitochondrial Dynamics. , 2015, Cell metabolism.

[82]  M. Donnino,et al.  Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial , 2015, Critical Care.

[83]  K. Drosatos,et al.  Pathophysiology of Sepsis-Related Cardiac Dysfunction: Driven by Inflammation, Energy Mismanagement, or Both? , 2015, Current Heart Failure Reports.

[84]  Mitchell M. Levy,et al.  Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion: Results From the Surviving Sepsis Campaign Database* , 2015, Critical care medicine.

[85]  M. Rosengart,et al.  Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation. , 2015, The Journal of surgical research.

[86]  Y. Zou,et al.  Rubicon Deficiency Enhances Cardiac Autophagy and Protects Mice From Lipopolysaccharide-induced Lethality and Reduction in Stroke Volume , 2015, Journal of cardiovascular pharmacology.

[87]  H. Ichijo,et al.  Mitochondrial proteolysis: its emerging roles in stress responses. , 2015, Biochimica et biophysica acta.

[88]  V. Nadkarni,et al.  Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells in Pediatric Septic Shock* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[89]  D. Corach,et al.  Cardiac mitochondrial biogenesis in endotoxemia is not accompanied by mitochondrial function recovery. , 2014, Free radical biology & medicine.

[90]  H. Wong,et al.  Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock , 2014, Critical Care.

[91]  C. McCall,et al.  SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome , 2014, Journal of leukocyte biology.

[92]  P. Marik,et al.  Sepsis-associated hyperlactatemia , 2014, Critical Care.

[93]  R. Schnellmann,et al.  Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury. , 2014, American journal of physiology. Renal physiology.

[94]  T. Sharshar,et al.  Neuropathological processes in sepsis , 2014, The Lancet Neurology.

[95]  M. Puskarich,et al.  Prognosis of emergency department patients with suspected infection and intermediate lactate levels: a systematic review. , 2014, Journal of critical care.

[96]  S. Nougaret,et al.  Sepsis Is Associated with a Preferential Diaphragmatic Atrophy: A Critically Ill Patient Study Using Tridimensional Computed Tomography , 2014, Anesthesiology.

[97]  G. Comi,et al.  Mitochondrial Changes in Platelets Are Not Related to Those in Skeletal Muscle during Human Septic Shock , 2014, PloS one.

[98]  P. Marik,et al.  Stress hyperlactataemia: present understanding and controversy. , 2014, The lancet. Diabetes & endocrinology.

[99]  D. Thorburn,et al.  Turn up the power – pharmacological activation of mitochondrial biogenesis in mouse models , 2014, British journal of pharmacology.

[100]  C. Leeuwenburgh,et al.  Effect of Intermittent Phrenic Nerve Stimulation During Cardiothoracic Surgery on Mitochondrial Respiration in the Human Diaphragm* , 2014, Critical care medicine.

[101]  Philip A. Kramer,et al.  A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: Implications for their use as bioenergetic biomarkers , 2014, Redox biology.

[102]  C. Hao,et al.  Nitrotyrosine Level Was Associated with Mortality in Patients with Acute Kidney Injury , 2013, PloS one.

[103]  C. Piantadosi,et al.  Peroxisome Proliferator-activated Receptor γ Co-activator 1-α as a Critical Co-activator of the Murine Hepatic Oxidative Stress Response and Mitochondrial Biogenesis in Staphylococcus aureus Sepsis* , 2013, The Journal of Biological Chemistry.

[104]  M. Singer,et al.  The metabolic phenotype of rodent sepsis: cause for concern? , 2013, Intensive Care Medicine Experimental.

[105]  L. Ferreira,et al.  Mechanical properties of respiratory muscles. , 2013, Comprehensive Physiology.

[106]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[107]  S. Hussain,et al.  Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction , 2013, Autophagy.

[108]  E. Elmér,et al.  Patients with sepsis exhibit increased mitochondrial respiratory capacity in peripheral blood immune cells , 2013, Critical Care.

[109]  Stephanie J. Reisinger,et al.  An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis , 2013, Science Translational Medicine.

[110]  T. Similowski,et al.  Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. , 2013, American journal of respiratory and critical care medicine.

[111]  F. Dal-Pizzol,et al.  Bioenergetics, Mitochondrial Dysfunction, and Oxidative Stress in the Pathophysiology of Septic Encephalopathy , 2013, Shock.

[112]  S. Homma,et al.  Peroxisome Proliferator–Activated Receptor-&ggr; Activation Prevents Sepsis-Related Cardiac Dysfunction and Mortality In Mice , 2013, Circulation. Heart failure.

[113]  E. Pearce,et al.  Metabolic pathways in immune cell activation and quiescence. , 2013, Immunity.

[114]  Andreas Marg,et al.  Critical illness myopathy and GLUT4: significance of insulin and muscle contraction. , 2013, American journal of respiratory and critical care medicine.

[115]  O. Nóbrega,et al.  Higher frequency of septic shock in septic patients with the 47C allele (rs4880) of the SOD2 gene. , 2013, Gene.

[116]  B. Halliwell.  The antioxidant paradox: less paradoxical now? , 2013, British journal of clinical pharmacology.

[117]  R. Hotchkiss,et al.  Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. , 2013, American journal of respiratory and critical care medicine.

[118]  D. Turnbull,et al.  Mitochondrial dysfunction and lipid accumulation in the human diaphragm during mechanical ventilation. , 2012, American journal of respiratory and critical care medicine.

[119]  G. B. Young,et al.  Sepsis-associated encephalopathy , 2012, Nature Reviews Neurology.

[120]  E. Ruiz-Pesini,et al.  Survival and mitochondrial function in septic patients according to mitochondrial DNA haplogroup , 2012, Critical Care.

[121]  M. Bhasin,et al.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. , 2011, The Journal of clinical investigation.

[122]  S. Homma,et al.  Inhibition of c-Jun-N-terminal Kinase Increases Cardiac Peroxisome Proliferator-activated Receptor α Expression and Fatty Acid Oxidation and Prevents Lipopolysaccharide-induced Heart Dysfunction* , 2011, The Journal of Biological Chemistry.

[123]  M. Donnino,et al.  Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock , 2011, Critical care.

[124]  S. Powers,et al.  Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness* , 2011, Critical care medicine.

[125]  D. Kelly,et al.  Toll-Like Receptor-Mediated Inflammatory Signaling Reprograms Cardiac Energy Metabolism by Repressing Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1 Signaling , 2011, Circulation. Heart failure.

[126]  P. Pai,et al.  Complete Induction of Autophagy Is Essential for Cardioprotection in Sepsis , 2011, Annals of surgery.

[127]  F. Bozza,et al.  Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5′-triphosphate synthase activity* , 2011, Critical care medicine.

[128]  M. Singer,et al.  Temporal changes in tissue cardiorespiratory function during faecal peritonitis , 2011, Intensive Care Medicine.

[129]  H. White,et al.  Clinical review: Ketones and brain injury , 2011, Critical care.

[130]  Jan Gunst,et al.  Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. , 2011, The Journal of clinical endocrinology and metabolism.

[131]  Steven B Heymsfield,et al.  Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. , 2010, The American journal of clinical nutrition.

[132]  H. Friberg,et al.  Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis , 2010, Critical care.

[133]  J. Aragonés,et al.  Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. , 2010, Cardiovascular research.

[134]  S. Lancel,et al.  Caspase-dependent protein phosphatase 2A activation contributes to endotoxin-induced cardiomyocyte contractile dysfunction* , 2010, Critical care medicine.

[135]  M. Singer,et al.  Survival in critical illness is associated with early activation of mitochondrial biogenesis. , 2010, American journal of respiratory and critical care medicine.

[136]  L. Azevedo.  Mitochondrial dysfunction during sepsis. , 2010, Endocrine, metabolic & immune disorders drug targets.

[137]  D. Payen,et al.  Bench-to-bedside review: Glucose and stress conditions in the intensive care unit , 2010, Critical care.

[138]  Xavier Capdevila,et al.  Adaptive Support Ventilation Prevents Ventilator-induced Diaphragmatic Dysfunction in Piglet: An In Vivo and In Vitro Study , 2010, Anesthesiology.

[139]  A. Knowlton,et al.  Mitochondria and heart failure: new insights into an energetic problem. , 2010, Minerva cardioangiologica.

[140]  Michael Bailey,et al.  Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study , 2010, Critical care.

[141]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[142]  R. Favory,et al.  Carbon Monoxide Rescues Mice from Lethal Sepsis by Supporting Mitochondrial Energetic Metabolism and Activating Mitochondrial Biogenesis , 2009, Journal of Pharmacology and Experimental Therapeutics.

[143]  Munish Goyal,et al.  Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock* , 2009, Critical care medicine.

[144]  T. Funahashi,et al.  Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. , 2009, Surgery.

[145]  C. Coopersmith,et al.  The sepsis seesaw: tilting toward immunosuppression , 2009, Nature Medicine.

[146]  M. Carraway,et al.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia. , 2009, Free radical biology & medicine.

[147]  R. Hotchkiss,et al.  Sepsis Induces Extensive Autophagic Vacuolization in Hepatocytes –a clinical and laboratory based study , 2009, Laboratory Investigation.

[148]  K. Guntupalli,et al.  WHOLE-BODY CO2 PRODUCTION AS AN INDEX OF THE METABOLIC RESPONSE TO SEPSIS , 2008, Shock.

[149]  J. Timmons,et al.  Dysregulation of Mitochondrial Dynamics and the Muscle Transcriptome in ICU Patients Suffering from Sepsis Induced Multiple Organ Failure , 2008, PloS one.

[150]  S. Lancel,et al.  Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction* , 2008, Critical care medicine.

[151]  S. Carr,et al.  A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.

[152]  Qiang He,et al.  Mitochondrial DNA haplogroup R predicts survival advantage in severe sepsis in the Han population , 2008, Genetics in Medicine.

[153]  Chad E Jones,et al.  Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death. , 2008, Journal of molecular and cellular cardiology.

[154]  M. Singer,et al.  Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis * , 2007, Critical care medicine.

[155]  F. Schweda,et al.  Proinflammatory cytokines cause down-regulation of renal chloride entry pathways during sepsis* , 2007, Critical care medicine.

[156]  P. Radermacher,et al.  Glucose metabolism and catecholamines , 2007, Critical care medicine.

[157]  A. Kurtz,et al.  Regulation of renal sodium transporters during severe inflammation. , 2007, Journal of the American Society of Nephrology : JASN.

[158]  M. Rossi,et al.  MYOCARDIAL STRUCTURAL CHANGES IN LONG-TERM HUMAN SEVERE SEPSIS/SEPTIC SHOCK MAY BE RESPONSIBLE FOR CARDIAC DYSFUNCTION , 2007, Shock.

[159]  O. Ljungqvist,et al.  Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. , 2006, American journal of physiology. Endocrinology and metabolism.

[160]  P. O’Connor.  RENAL OXYGEN DELIVERY: MATCHING DELIVERY TO METABOLIC DEMAND , 2006, Clinical and experimental pharmacology & physiology.

[161]  A. Demoule,et al.  Endotoxin triggers nuclear factor-kappaB-dependent up-regulation of multiple proinflammatory genes in the diaphragm. , 2006, American journal of respiratory and critical care medicine.

[162]  B. Levy.  Lactate and shock state: the metabolic view , 2006, Current opinion in critical care.

[163]  R. Favory,et al.  Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. , 2006, Journal of the American College of Cardiology.

[164]  R. Favory,et al.  Sphingosine impairs mitochondrial function by opening permeability transition pore. , 2006, Mitochondrion.

[165]  E. Crouser,et al.  Calcineurin regulates myocardial function during acute endotoxemia. , 2006, American journal of respiratory and critical care medicine.

[166]  M. Singer,et al.  Mitochondrial dysfunction in patients with severe sepsis: an EPR interrogation of individual respiratory chain components. , 2006, Biochimica et biophysica acta.

[167]  L. Hor,et al.  Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis , 2006, Critical care.

[168]  Sheldon Magder,et al.  Reactive oxygen species: toxic molecules or spark of life? , 2006, Critical care.

[169]  D. Turnbull,et al.  Mitochondrial DNA and survival after sepsis: a prospective study , 2005, The Lancet.

[170]  X. Leverve.  Lactate in the intensive care unit: pyromaniac, sentinel or fireman? , 2005, Critical care.

[171]  G. Supinski,et al.  Downregulation of diaphragm electron transport chain and glycolytic enzyme gene expression in sepsis. , 2005, Journal of applied physiology.

[172]  G. Martin,et al.  Albumin: Biochemical properties and therapeutic potential , 2005, Hepatology.

[173]  R. Favory,et al.  Ventricular Myocyte Caspases Are Directly Responsible for Endotoxin-Induced Cardiac Dysfunction , 2005, Circulation.

[174]  P. Bollaert,et al.  Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study , 2005, The Lancet.

[175]  C. Wolf‐peeters,et al.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients , 2005, The Lancet.

[176]  M. Carraway,et al.  Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. , 2004, Cardiovascular research.

[177]  V. Borutaite,et al.  Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. , 2004, Biochimica et biophysica acta.

[178]  S. Mordon,et al.  Endotoxin-induced myocardial dysfunction: Evidence for a role of sphingosine production* , 2004, Critical care medicine.

[179]  A. Sollevi,et al.  Complement activation, endothelin‐1 and neuropeptide Y in relation to the cardiovascular response to endotoxin‐induced systemic inflammation in healthy volunteers , 2004, Acta anaesthesiologica Scandinavica.

[180]  A. Lückhoff,et al.  Impairment of glucose metabolism in hearts from rats treated with endotoxin. , 2003, Cardiovascular research.

[181]  Peter Radermacher,et al.  Metabolic alterations in sepsis and vasoactive drug–related metabolic effects , 2003, Current opinion in critical care.

[182]  J. Vincent,et al.  Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? , 2003, Critical care medicine.

[183]  X. Leverve.  Hyperglycemia and oxidative stress: complex relationships with attractive prospects , 2003, Intensive Care Medicine.

[184]  R. Moots,et al.  The Mitochondrial Network of Human Neutrophils: Role in Chemotaxis, Phagocytosis, Respiratory Burst Activation, and Commitment to Apoptosis 1 , 2003, The Journal of Immunology.

[185]  John Land,et al.  Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.

[186]  G. Biolo,et al.  Bench-to-bedside review: Lactate and the lung , 2002, Critical care.

[187]  R. Cooper,et al.  Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. , 2002, American journal of physiology. Endocrinology and metabolism.

[188]  M. Adib-Conquy,et al.  Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. , 2001, American journal of respiratory and critical care medicine.

[189]  C. Zauner,et al.  Similar metabolic responses to standardized total parenteral nutrition of septic and nonseptic critically ill patients. , 2001, The American journal of clinical nutrition.

[190]  M. Georgieff,et al.  Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock , 2001, Intensive Care Medicine.

[191]  M. Georgieff,et al.  Effect of dopexamine on hepatic metabolic activity in patients with septic shock. , 2001, Shock.

[192]  R. Hotchkiss,et al.  Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.

[193]  S. Jakob,et al.  Metabolic effects of vasoactive agents , 2001, Current Opinion in Anaesthesiology.

[194]  J. Vincent,et al.  The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis , 2001, Critical care medicine.

[195]  A. Mebazaa,et al.  Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. , 2000, American journal of respiratory and critical care medicine.

[196]  R. Little,et al.  Insulin resistance and substrate utilization in human endotoxemia. , 2000, The Journal of clinical endocrinology and metabolism.

[197]  B. Halliwell.  The antioxidant paradox , 2000, The Lancet.

[198]  G. Hill,et al.  Components of energy expenditure in patients with severe sepsis and major trauma: a basis for clinical care. , 1999, Critical care medicine.

[199]  R. Hotchkiss,et al.  Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.

[200]  J. Vincent,et al.  Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. , 1999, Metabolism: clinical and experimental.

[201]  R. Little,et al.  Selective impairment of glucose storage in human sepsis , 1999, The British journal of surgery.

[202]  M. Georgieff,et al.  Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. , 1999, Critical care medicine.

[203]  K. Reinhart,et al.  Total plasma antioxidant capacity is not always decreased in sepsis. , 1998, Critical care medicine.

[204]  G. Brown,et al.  Cellular energy utilization and molecular origin of standard metabolic rate in mammals. , 1997, Physiological reviews.

[205]  C. Hinds,et al.  Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. , 1997, Critical care medicine.

[206]  M. Stumvoll,et al.  Renal glucose production and utilization: new aspects in humans , 1997, Diabetologia.

[207]  R Bellomo,et al.  Release of lactate by the lung in acute lung injury. , 1997, Advances in experimental medicine and biology.

[208]  M. Georgieff,et al.  Effects of a Dobutamine‐induced Increase in Splanchnic Blood Flow on Hepatic Metabolic Activity in Patients with Septic Shock , 1997, Anesthesiology.

[209]  P. Nabet,et al.  Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study , 1997, Intensive Care Medicine.

[210]  K. Reinhart,et al.  Epinephrine impairs splanchnic perfusion in septic shock. , 1997, Critical care medicine.

[211]  F. Buttgereit,et al.  A hierarchy of ATP-consuming processes in mammalian cells. , 1995, The Biochemical journal.

[212]  M. Stumvoll,et al.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. , 1995, The Journal of clinical investigation.

[213]  M. Lange,et al.  Hepatic metabolic response to injury and sepsis. , 1995, Surgery.

[214]  P. Radermacher,et al.  Prostacyclin improves glucose utilization in patients with sepsis. , 1994, Journal of critical care.

[215]  P. Boekstegers,et al.  Skeletal muscle partial pressure of oxygen in patients with sepsis , 1994, Critical care medicine.

[216]  D. Gore,et al.  Derangements in peripheral glucose and oxygen utilization induced by catabolic hormones , 1993, Critical care medicine.

[217]  S. Matthaei,et al.  Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock , 1993, Critical care medicine.

[218]  J. Orens,et al.  Impaired β‐adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines , 1993, Critical care medicine.

[219]  H. Ensinger,et al.  Relationship between infusion rates, plasma concentrations, and cardiovascular and metabolic effects during the infusion of norepinephrine in healthy volunteers , 1992, Critical care medicine.

[220]  S. Liggett,et al.  Energy expenditures of mechanically ventilated nonsurgical patients. , 1990, Chest.

[221]  A C Allison,et al.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. , 1990, The Journal of clinical investigation.

[222]  K. Jungermann,et al.  Functional specialization of different hepatocyte populations. , 1989, Physiological reviews.

[223]  W. Law,et al.  Myocardial Insulin Resistance During Acute Endotoxin Shock in Dogs , 1988, Diabetes.

[224]  C. Branger,et al.  Effects of sepsis on diaphragmatic function in rats. , 1988, The American review of respiratory disease.

[225]  J. Dhainaut,et al.  Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. , 1987, Circulation.

[226]  A. Ellrodt,et al.  Sepsis and septic shock. , 1986, Emergency medicine clinics of North America.

[227]  C. Roussos,et al.  Respiratory muscle fatigue: a cause of ventilatory failure in septic shock. , 1985, Journal of applied physiology.

[228]  D. Wilmore,et al.  Combined Hormonal Infusion Simulates the Metabolic Response to Injury , 1984, Annals of surgery.

[229]  A. Gasparetto,et al.  EFFECT OF TISSUE HYPOXIA AND SEPTIC SHOCK ON HUMAN SKELETAL MUSCLE MITOCHONDRIA , 1983, The Lancet.

[230]  T. Herlin,et al.  Energy metabolism of human neutrophils during phagocytosis. , 1982, The Journal of clinical investigation.

[231]  A. Mason,et al.  Effect of Injury and Infection on Visceral Metabolism and Circulation , 1980, Annals of surgery.

[232]  J. Metcalf,et al.  H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells. , 1977, The Journal of clinical investigation.

[233]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[234]  R. Bing,et al.  Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism of the human heart. , 1953, The American journal of medicine.

[235]  B. Billing,et al.  The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man , 1951, The Journal of physiology.

[236]  F. Shafiee,et al.  Coenzyme Q10 improves the survival and reduces inflammatory markers in septic patients. , 2020, Bratislavske lekarske listy.

[237]  P. Duann,et al.  Mitochondria Damage and Kidney Disease. , 2017, Advances in experimental medicine and biology.

[238]  D. Annane,et al.  Cognitive decline after sepsis. , 2015, The Lancet. Respiratory medicine.

[239]  Y. Naito,et al.  Potential role of oxidative protein modification in energy metabolism in exercise. , 2014, Sub-cellular biochemistry.

[240]  J. Vincent,et al.  Circulatory shock. , 2013, The New England journal of medicine.

[241]  G. Van den Berghe,et al.  Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients. , 2012, The Journal of clinical endocrinology and metabolism.

[242]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[243]  C. Coopersmith,et al.  Mitochondrial Pathways Occurs by both the Death Receptor and Accelerated Lymphocyte Death in Sepsis , 2005 .

[244]  B A Mizock,et al.  Alterations in carbohydrate metabolism during stress: a review of the literature. , 1995, The American journal of medicine.

[245]  S. Soltoff,et al.  ATP and the regulation of renal cell function. , 1986, Annual review of physiology.

[246]  A. Mason,et al.  Effect of injury and infection on visceral metabolism and circulation. , 1980 .